Medtronic plcMDTCash flow

Market cap
$125B
P/E ratio
2015/042016/042017/042018/042019/042020/042021/042022/042023/042024/042025/04
Depreciation & amortization1,3062,8202,9172,6442,6592,6632,7022,7072,6972,6472,861
Stock-based compensation439375348344290297344359355393429
Cash from operations 4,9025,2186,8804,6847,0077,2346,2407,3466,0396,7877,044
Capital expenditures-571-1,046-1,254-1,068-1,134-1,213-1,355-1,368-1,459-1,587-1,859
Cash from investing -17,0582,245-1,5715,858-774-3,203-2,866-1,659-3,493-2,366-1,937
Repurchases of common stock1,9202,8303,5442,1712,8771,3266522,5446452,1383,235
Proceeds from issuance of term debt, net19,942-2,140217,7945,5687,172-5,409-3,209
Repayments of term debt1,2685,1328637,3707,9486,1107,36716,012--
Cash from financing 15,949-9,543-3,283-11,954-5,431-4,198-4,136-5,336-4,960-4,450-4,361
Free cash flow
FCF margin (%)